Citadel Advisors’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.3K | Sell |
30,907
-17,877
| -37% | -$54K | ﹤0.01% | 5298 |
|
|
2025
Q1 | $149K | Buy |
+48,784
| New | +$149K | ﹤0.01% | 4997 |
|
|
2023
Q3 | – | Sell |
-12,598
| Closed | -$57.9K | – | 6305 |
|
|
2023
Q2 | $57.9K | Buy |
+12,598
| New | +$57.9K | ﹤0.01% | 4948 |
|
|
2022
Q4 | – | Sell |
-1,373
| Closed | -$20K | – | 6509 |
|
|
2022
Q3 | $20K | Sell |
1,373
-11,203
| -89% | -$163K | ﹤0.01% | 5535 |
|
|
2022
Q2 | $226K | Buy |
12,576
+10,533
| +516% | +$189K | ﹤0.01% | 4901 |
|
|
2022
Q1 | $61K | Buy |
2,043
+420
| +26% | +$12.5K | ﹤0.01% | 5840 |
|
|
2021
Q4 | $70K | Sell |
1,623
-112
| -6% | -$4.83K | ﹤0.01% | 6053 |
|
|
2021
Q3 | $124K | Sell |
1,735
-1,652
| -49% | -$118K | ﹤0.01% | 5720 |
|
|
2021
Q2 | $388K | Sell |
3,387
-2,424
| -42% | -$278K | ﹤0.01% | 4957 |
|
|
2021
Q1 | $603K | Buy |
5,811
+3,044
| +110% | +$316K | ﹤0.01% | 4415 |
|
|
2020
Q4 | $132K | Buy |
2,767
+1,896
| +218% | +$90.4K | ﹤0.01% | 4616 |
|
|
2020
Q3 | $24K | Sell |
871
-910
| -51% | -$25.1K | ﹤0.01% | 4509 |
|
|
2020
Q2 | $68K | Buy |
1,781
+648
| +57% | +$24.7K | ﹤0.01% | 4306 |
|
|
2020
Q1 | $56K | Buy |
+1,133
| New | +$56K | ﹤0.01% | 4520 |
|
|
2019
Q3 | – | Sell |
-757
| Closed | -$38K | – | 5006 |
|
|
2019
Q2 | $38K | Buy |
+757
| New | +$38K | ﹤0.01% | 4401 |
|
|
2018
Q2 | – | Sell |
-889
| Closed | -$37K | – | 4451 |
|
|
2018
Q1 | $37K | Buy |
+889
| New | +$37K | ﹤0.01% | 3788 |
|